Back to Protocols & Dosing
Protocols & Dosing•••8 min read

5-Amino-1MQ Dosage: Oral vs SubQ Milligram Ranges Explained

5-Amino-1MQ dosage explained: how oral vs subcutaneous milligram tables differ in community logs versus preclinical NNMT research. Educational only—not a protocol.

PeptIQ Team
Peptide Research & Education
5-Amino-1MQ Dosage: Oral vs SubQ Milligram Ranges Explained

PeptIQ app

Log your NAD+ protocol in PeptIQ

Turn this NAD+ guide into a living protocol — doses, vials, and history in one place.

Track NAD+Open web app

iOS, Android, and web

Research supplier

NAD+ listings are for laboratory / research use only — not for human consumption.

Research use only. Partner link. PeptIQ may earn a referral fee. Not medical advice.

Ask PeptIQ

Two taps on our guided quiz, then keep going in iMessage with sources — not Instagram screenshots.

Start the quizOr try Peptide X Quiz →

# 5-Amino-1MQ Dosage: Oral vs SubQ Milligram Ranges Explained

> Note: PeptIQ is not a medical provider. 5-Amino-1MQ is a research compound, not a peptide in the clinical-peptide sense. This article is educational only.

The existing 5-Amino-1MQ stack guide covers NNMT inhibition and why people discuss it next to GLP-1 agonists and MOTS-c. Search still wants a dedicated 5 amino 1mq dosage page, including oral vs subQ.

5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule NNMT inhibitor in preclinical metabolic work. That is a different evidence class from a weekly incretin trial. Dose tables on forums should be read as community habit, not as a labeled schedule.

Evidence tier

LayerStrengthLimit
Preclinical NNMT / 5-Amino-1MQ papersMechanism hypotheses in animals and cellsNo consumer milligram label
Stack blogs and logsOral capsule versus reconstituted powder storiesObservational
In-app entriesWhat people record as mg and routeNot outcomes

Do not invent trial PMIDs for a compound that is still mostly preclinical. If a specific paper is not already in the PeptIQ citation corpus, omit it.

Oral versus subcutaneous in community write-ups

Route people nameWhy they name itCaution
Oral capsulesConvenience, daily habit, "research chem" listingsAbsorption and identity are listing-dependent
Subcutaneous reconstituted powderPeople copy peptide-vial habits5-Amino-1MQ is not a typical lyophilized peptide workflow

Educational reconstitution math, if someone is holding a claimed powder, is the same generic formula as other research chemicals sold as cakes:

Concentration (mg/mL) = labeled mg ÷ diluent mL

That math does not make the powder 5-Amino-1MQ, and it does not make subcutaneous use a studied human route.

Research-reference ranges versus forum tables

Community tables often discuss daily milligram-scale oral amounts, sometimes split, sometimes stacked with a GLP-1 log or MOTS-c. Those numbers are not a starting-dose instruction. They are what dosage threads repeat.

PeptIQ users who log 5-Amino-1MQ more often record an oral daily field than an injection field. That is a logging observation.

What this page will not do

  • Convert a GLP-1 weekly milligram into a 5-Amino-1MQ oral milligram
  • Treat "visceral fat" marketing as a trial endpoint
  • Publish a buy or source list

Related reading: the 5-Amino-1MQ stack guide for mechanism, the MOTS-c dosage guide for the mitochondrial neighbor, and NAD+ reconstitution education for the NAD-pool conversation people attach to NNMT.

Frequently Asked Questions

Q: Is there an official 5-Amino-1MQ human dose?

A: No labeled consumer schedule. Preclinical NNMT work and community logs are different evidence tiers. Treat forum milligram tables as observational language, not a protocol.

Q: Oral or subcutaneous?

A: Community write-ups mention both. Oral capsules dominate convenience stories. SubQ habits often copy peptide-vial workflows even though 5-Amino-1MQ is not a typical lyophilized peptide product.

Q: Can I convert a retatrutide weekly dose into a 5-Amino-1MQ oral milligram?

A: No. Different mechanisms, different evidence classes. Do not map GLP-1 weekly milligrams onto NNMT-inhibitor forum tables.

Bottom line

5-Amino-1MQ dosage queries outrun the human literature. Oral versus subcutaneous is a community handling split, not a comparative trial. Figures on forums are not a protocol.

Share this article

Track Your Peptide Protocols

Use PeptIQ to log injections and vial supply, use peptiq.io calculators for math on the web, and keep protocols organized.

Stay ahead of the peptide conversation

Weekly-ish notes on new research, wiki trends, and practical tracking tips. No spam — unsubscribe anytime.

Educational updates only — not medical advice. Privacy